Oncolytics Biotech Inc. (ONCY) vs Talphera, Inc. (TLPH)
A side-by-side comparison of Oncolytics Biotech Inc. and Talphera, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ONCY
Oncolytics Biotech Inc.
$0.60HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
TLPH
Talphera, Inc.
$1.11HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — ONCY vs TLPH
growth of $100 · dividends reinvested · last 10yONCY -76.8% (-13.6%/yr)TLPH -98.5% (-34.2%/yr)ONCY compounded faster over this window
Log scale — wide-divergence pair
ONCY TLPH
ONCY vs TLPH: by the numbers
- •ONCY is the larger company ($60M vs $58M market cap).
- •Both run net losses; ONCY's is the smaller (0.00% vs -1507600.00% net margin).
Metrics side by side
Valuation
| Metric | ONCY | TLPH |
|---|---|---|
| P/S ratio | N/A | 57608.56 |
| P/B ratio | N/A | 4.00 |
Profitability
| Metric | ONCY | TLPH |
|---|---|---|
| Gross margin | 0.00% | 100.00% |
| Operating margin | 0.00% | -48157.14% |
| Net margin | 0.00% | -1507600.00% |
| ROE | N/A | -104.65% |
| ROIC | -1235.48% | -65.20% |
Growth (annualized)
| Metric | ONCY | TLPH |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -79.92% |
| Total return CAGR (5Y) | -21.00% | -43.65% |
Frequently asked
- How have ONCY and TLPH total returns compared?
- Over the past 10 years, ONCY delivered -12.54% and TLPH delivered -34.23% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.